$XENE Xenon Pharmaceuticals Inc. Insider Trading
Get free email notifications about insider trading in Xenon Pharmaceuticals Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Xenon Pharmaceuticals Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Xenon Pharmaceuticals Inc. for free.
CIK Number: 0001582313
IRS Number: 980661854
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: XENE
Company Address: 200 - 3650 GILMORE WAY BURNABY V5G 48W
Market Capitalization: $145.83M
Prev close: $8.20
Average Daily Volume: 44,169
Days Low: $8.15
Year Low: $5.65
Year High: $8.75
Xenon Pharmaceuticals Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 04 2021 | XENE | Xenon Pharmaceutic ... | PATOU GARY | Director | Option Exercise | A | 18.56 | 10,000 | 185,600 | 10,000 | |
Jun 04 2021 | XENE | Xenon Pharmaceutic ... | PATOU GARY | Director | Buy | L | 19.49 | 100 | 1,949 | 100 | 0 to 100 |
Jun 01 2021 | XENE | Xenon Pharmaceutic ... | ROBIN SHERRINGTON | EVP, Strategy & Inn ... | Option Exercise | M | 3.85 | 13,374 | 51,490 | 0 | |
Jun 01 2021 | XENE | Xenon Pharmaceutic ... | ROBIN SHERRINGTON | EVP, Strategy & Inn ... | Option Exercise | M | 3.76 | 12,345 | 46,417 | 0 | |
Jun 01 2021 | XENE | Xenon Pharmaceutic ... | ROBIN SHERRINGTON | EVP, Strategy & Inn ... | Sell | S | 18.81 | 2,912 | 54,775 | 32,232 | 35.1 K to 32.2 K (-8.29 %) |
Jun 01 2021 | XENE | Xenon Pharmaceutic ... | ROBIN SHERRINGTON | EVP, Strategy & Inn ... | Sell | S | 18.81 | 3,155 | 59,346 | 35,144 | 38.3 K to 35.1 K (-8.24 %) |
Jun 01 2021 | XENE | Xenon Pharmaceutic ... | ROBIN SHERRINGTON | EVP, Strategy & Inn ... | Payment of Exercise | F | 18.91 | 2,192 | 41,451 | 38,299 | 40.5 K to 38.3 K (-5.41 %) |
Jun 01 2021 | XENE | Xenon Pharmaceutic ... | ROBIN SHERRINGTON | EVP, Strategy & Inn ... | Buy | M | 3.85 | 13,374 | 51,490 | 40,491 | 27.1 K to 40.5 K (+49.32 %) |
Jun 01 2021 | XENE | Xenon Pharmaceutic ... | ROBIN SHERRINGTON | EVP, Strategy & Inn ... | Payment of Exercise | F | 18.91 | 2,024 | 38,274 | 27,117 | 29.1 K to 27.1 K (-6.95 %) |
Jun 01 2021 | XENE | Xenon Pharmaceutic ... | ROBIN SHERRINGTON | EVP, Strategy & Inn ... | Buy | M | 3.76 | 12,345 | 46,417 | 29,141 | 16.8 K to 29.1 K (+73.50 %) |
Mar 15 2021 | XENE | Xenon Pharmaceutic ... | Von Seggern Christopher | Chief Commercial Of ... | Option Exercise | A | 20.55 | 60,000 | 1,233,000 | 60,000 | |
Mar 15 2021 | XENE | Xenon Pharmaceutic ... | ROBIN SHERRINGTON | EVP, Strategy & Inn ... | Option Exercise | A | 20.55 | 65,000 | 1,335,750 | 65,000 | |
Mar 15 2021 | XENE | Xenon Pharmaceutic ... | PIMSTONE SIMON N. | CEO | Option Exercise | A | 20.55 | 225,000 | 4,623,750 | 225,000 | |
Mar 15 2021 | XENE | Xenon Pharmaceutic ... | MORTIMER IAN | PRESIDENT & CFO | Option Exercise | A | 20.55 | 100,000 | 2,055,000 | 100,000 | |
Mar 15 2021 | XENE | Xenon Pharmaceutic ... | EMPFIELD JAMES R. | EVP, Drug Discovery | Option Exercise | A | 20.55 | 65,000 | 1,335,750 | 65,000 |